Traynor Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
960
+40
+4% +$13.7K 0.02% 234
2026
Q1
$321K Sell
920
-15
-2% -$5.35K 0.02% 235
2025
Q4
$306K Sell
935
-21
-2% -$6.66K 0.02% 249
2025
Q3
$270K Buy
956
+62
+7% +$18K 0.02% 261
2025
Q2
$260K Buy
894
+201
+29% +$56.9K 0.02% 201
2025
Q1
$216K Sell
693
-168
-20% -$49.6K 0.02% 200
2024
Q4
$224K Buy
861
+213
+33% +$63.2K 0.02% 226
2024
Q3
$209K Sell
648
-26
-4% -$8.51K 0.01% 226
2024
Q2
$210K Sell
674
-19,625
-97% -$5.77M 0.02% 214
2024
Q1
$5.77M Buy
20,299
+1,358
+7% +$397K 0.5% 37
2023
Q4
$5.46M Buy
18,941
+1,650
+10% +$450K 0.56% 35
2023
Q3
$4.65M Buy
17,291
+1,044
+6% +$261K 0.58% 37
2023
Q2
$3.61M Sell
16,247
-179
-1% -$41.5K 0.44% 42
2023
Q1
$3.97M Sell
16,426
-159
-1% -$39K 0.57% 37
2022
Q4
$4.36M Sell
16,585
-228
-1% -$61.1K 0.61% 36
2022
Q3
$3.79M Buy
16,813
+97
+0.6% +$23.5K 0.68% 33
2022
Q2
$4.07M Sell
16,716
-1,303
-7% -$319K 0.71% 35
2022
Q1
$4.36M Buy
18,019
+22
+0.1% +$5.05K 0.57% 37
2021
Q4
$4.05M Sell
17,997
-8
-0% -$1.69K 0.48% 49
2021
Q3
$3.83M Sell
18,005
-127
-0.7% -$29.2K 0.52% 44
2021
Q2
$4.51M Buy
18,132
+383
+2% +$94.2K 0.63% 39
2021
Q1
$4.42M Buy
17,749
+612
+4% +$146K 0.73% 36
2020
Q4
$3.94M Sell
17,137
-1,269
-7% -$293K 0.7% 36
2020
Q3
$4.18M Buy
18,406
+624
+4% +$155K 0.96% 23
2020
Q2
$4.19M Buy
17,782
+1,945
+12% +$444K 1.01% 20
2020
Q1
$3.21M Buy
15,837
+831
+6% +$182K 1.14% 20
2019
Q4
$3.62M Buy
15,006
+137
+0.9% +$30.2K 0.97% 25
2019
Q3
$2.88M Buy
14,869
+1,237
+9% +$237K 0.9% 28
2019
Q2
$2.54M Sell
13,632
-247
-2% -$44.2K 0.83% 27
2019
Q1
$2.64M Buy
13,879
+1,234
+10% +$236K 0.88% 25
2018
Q4
$2.46M Buy
12,645
+1,237
+11% +$241K 1.03% 24
2018
Q3
$2.36M Buy
11,408
+855
+8% +$169K 0.77% 27
2018
Q2
$1.95M Buy
10,553
+1,123
+12% +$199K 0.71% 30
2018
Q1
$1.61M Buy
9,430
+1,157
+14% +$212K 0.65% 31
2017
Q4
$1.44M Buy
8,273
+2,248
+37% +$398K 0.61% 35
2017
Q3
$1.12M Buy
6,025
+350
+6% +$62K 0.53% 41
2017
Q2
$977K Buy
5,675
+1,487
+36% +$242K 0.48% 45
2017
Q1
$685K Buy
4,188
+1,011
+32% +$168K 0.38% 57
2016
Q4
$490K Sell
3,177
-380
-11% -$57.2K 0.32% 66
2016
Q3
$573K Buy
3,557
+114
+3% +$19.3K 0.41% 54
2016
Q2
$531K Buy
3,443
+270
+9% +$42K 0.42% 54
2016
Q1
$475K Sell
3,173
-87
-3% -$12.9K 0.38% 57
2015
Q4
$529K Sell
3,260
-72
-2% -$11.3K 0.38% 60
2015
Q3
$460K Buy
3,332
+649
+24% +$102K 0.4% 55
2015
Q2
$412K Buy
2,683
+1,403
+110% +$225K 0.34% 64
2015
Q1
$204K Buy
+1,280
New +$202K 0.2% 108

Other funds holding AMGN

Traynor Capital Management's AMGN Position: Q2 2026 in Review

Traynor Capital Management increased its Amgen (AMGN) stake by 4.3% in Q2 2026, buying an estimated $13.7K and bringing the position to 960 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #234.

Traynor Capital Management first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.77M in Q1 2024. 985 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Traynor Capital Management held 960 shares of Amgen worth $348K as of Q2 2026.
  • Traynor Capital Management bought 40 Amgen shares in Q2 2026, an estimated $13.7K.
  • Amgen made up 0.02% of Traynor Capital Management's portfolio in Q2 2026, its #234 holding.
  • Traynor Capital Management first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
  • Traynor Capital Management's Amgen position peaked at $5.77M in Q1 2024.
  • 985 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.